Looking to publish in Inflammopharmacology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginInflammopharmacology is a comprehensive resource on all aspects of inflammation and its pharmacological control, emphasizing pain therapy. It compares different inflammatory states and their causes, examines the actions, therapeutic efficacy and safety of drugs used in the treatment of inflammatory conditions, and covers Conditional Pharmacology/Toxicology, Rheumatology, Gastroenterology, Neuro-Inflammation, and Novel Drugs, Natural Products and Nutraceuticals, with particular emphasis on methods of measurement of clinical response effects of new agents and adverse effects from anti-rheumatic drugs, as well as the safety and efficacy of non-prescription and prescription NSAIDs and analgesics.
Looking to publish in Inflammopharmacology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Inflammopharmacology accepts the following article types. Click on an article type to view submission instructions.
Research
Reviews
Brief Report
Correspondence
Recent Publications
Cannabinoid receptor agonist WIN 55,212-2 modulates systemic inflammatory and oxidative stress responses in streptozotocin-induced diabetic rats
Fatma Kubra Tombulturk, Huri Dedeakayogullari Demirci, Zeynep Gizem Todurga Seven, Kubra Cigdem Pekkoc-Uyanik
Pharmacological evaluation of Schinus terebinthifolius leaf polysaccharides: from chemical profiling to anti-inflammatory and wound-healing applications
Arij Bedoui, Ilhem Rjeibi, Walid Elfalleh, Anouar Feriani, Hamdi Bendif, Sulaiman A. Alsalamah, Guillaume Pierre, Philippe Michaud, Fadwa Yahya, Zouhaier Abbes, Nizar Tlili
In vivo and in vitro investigation of skin anti-inflammatory effect of Sumac (Rhus coriaria L.)
Marco Fumagalli, Giulia Martinelli, Silvio Sosa, Zixiong Tang, Michela Carlin, Safwa Moheb El Haddad, Nicole Maranta, Carola Pozzoli, Chiara Di Lorenzo, Giovanna Baron, Stefano Piazza, Marco Pelin, Mario Dell’Agli, Enrico Sangiovanni
Empagliflozin protects against indomethacin-induced gastric injury in rats: evidence from inflammatory, apoptotic, and early PI3K/Akt/VEGF-related changes
Ayça Toprak-Semiz, Atilla Topçu, Esra Deniz, Çiğdem Öztürk, Sibel Mataracı Karakaş, İhsan Nalkıran, Hatice Sevim Nalkıran, Medeni Arpa
Exploring the novel ameliorative effect of date palm pollen extract in inflammatory bowel disease
Bassant E. Samier, Linda K. Mujahed, Shahd Ragab, Nada Badran Nagieb, Aya A. El-fiky, Ayatollah A. El-Shorbagy
Frequently asked questions
How long does it take to publish?
All manuscripts are reviewed anonymously by at least two independent reviewers. Articles are published online after receipt of the corrected proofs.
Reformat to Inflammopharmacology using Livewrite PremiumIs a cover letter required?
An accompanying letter submitted with the manuscript should state that the paper is original, unpublished, and not under consideration elsewhere. The corresponding author should mention unpublished material included in the manuscript in a cover letter to the editor.
Reformat to Inflammopharmacology using Livewrite PremiumWhat are the publication costs?
Open access APC: £3290.00 GBP / $5290.00 USD / €4090.00 EUR. Subscription publishing is available with no APC.
Reformat to Inflammopharmacology using Livewrite Premium